Publication | Closed Access

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

PsychiatryAdd-on Pilot StudyPsychotropic MedicationSubcortical Ischemic DepressionPharmacologyMajor DepressionPsychopharmacologyDepressionPharmacotherapyMedicineCyclooxygenase-2 Inhibitor Celecoxib